Introduction
Acanthosis nigricans is usually identified during a clinical examination rather than by a single definitive laboratory test. It appears as areas of skin thickening and darkening, most often in body folds such as the neck, armpits, groin, or under the breasts. Because these skin changes can reflect different underlying processes, accurate diagnosis matters. In some people, acanthosis nigricans is linked to insulin resistance and metabolic disease; in others, it may be associated with medications, endocrine disorders, or, more rarely, internal malignancy. The diagnostic approach is therefore not only about naming the skin finding, but also about determining why it is present.
Doctors diagnose acanthosis nigricans by combining the appearance and distribution of the lesions with medical history, physical examination, and, when needed, laboratory studies or skin biopsy. The main diagnostic task is to distinguish acanthosis nigricans from other causes of hyperpigmented or thickened skin and to identify any associated condition that requires treatment.
Recognizing Possible Signs of the Condition
The first clue is the characteristic skin change itself. Acanthosis nigricans typically causes a symmetric, velvety, thickened plaque with a brown, gray-brown, or sometimes black appearance. The surface may feel slightly raised or soft rather than rough. These patches most often occur in intertriginous areas, which are regions where skin rubs against skin and moisture is trapped. The neck is the classic site, but the axillae, groin, inner thighs, elbows, knees, and knuckles may also be involved.
Although the color change draws attention, the texture is often more informative to clinicians. The thickened, velvety quality reflects epidermal hyperplasia, especially increased proliferation of keratinocytes, which is why the diagnosis is based on morphology and location rather than pigmentation alone. Some patients notice itchiness, mild odor, or skin tags in the same areas, but many have no discomfort. When the process is extensive, rapidly progressive, or appears on unusual sites such as the lips, palms, or mucous membranes, doctors may look more carefully for a secondary cause.
In children and adolescents, acanthosis nigricans commonly raises suspicion for insulin resistance, obesity-related metabolic changes, or, less commonly, endocrine disease. In adults, especially when the onset is sudden or widespread, physicians also consider drug-related causes and, in selected cases, paraneoplastic acanthosis nigricans associated with internal cancer.
Medical History and Physical Examination
Diagnosis begins with a targeted history. A clinician will ask when the skin changes first appeared, whether they have spread, and whether they developed gradually or suddenly. Slow, longstanding changes often point toward metabolic causes, while abrupt onset, extensive involvement, or marked progression may prompt investigation for more serious underlying disease.
Medical history helps identify risk factors that are strongly associated with acanthosis nigricans. These include obesity, type 2 diabetes, prediabetes, polycystic ovary syndrome, gestational diabetes, metabolic syndrome, and a family history of insulin resistance. The clinician may ask about weight changes, menstrual irregularity, symptoms of androgen excess, fatigue, thirst, increased urination, or other signs of abnormal glucose metabolism. A medication history is also important because certain drugs can trigger or worsen the condition. Examples include systemic corticosteroids, niacin, some oral contraceptives, growth hormone, and medications that can promote insulin resistance.
During the physical examination, the doctor evaluates the appearance and distribution of the lesions and looks for accompanying findings that suggest a cause. They may check for skin tags, obesity, signs of hirsutism or acne, blood pressure elevation, and features of insulin resistance or metabolic syndrome. In children, growth pattern and pubertal status may also be relevant. In some patients, the skin is examined for involvement of the oral mucosa or other atypical sites, which can change the level of concern for an underlying systemic disorder.
The examination also helps distinguish acanthosis nigricans from simple post-inflammatory hyperpigmentation or friction-related darkening. The combination of symmetry, velvety texture, and location in folds strongly supports the diagnosis. If the clinical picture is uncertain, further testing may be used to confirm the diagnosis or to rule out alternative conditions.
Diagnostic Tests Used for Acanthosis nigricans
There is no single blood test that diagnoses acanthosis nigricans itself. Instead, tests are used to evaluate the suspected underlying cause and to exclude other disorders that can resemble it. The choice of tests depends on the patient’s age, severity of the skin findings, and associated symptoms.
Laboratory tests are the most common next step. Blood glucose testing, including fasting plasma glucose and hemoglobin A1c, helps assess for prediabetes and diabetes. These tests reflect how much glucose is circulating in the blood and whether chronic elevation is present. Because insulin resistance is a frequent driver of acanthosis nigricans, clinicians may also order fasting insulin, though this is not always necessary in routine practice. Lipid testing is often performed because dyslipidemia commonly accompanies insulin resistance and metabolic syndrome. Depending on the clinical context, doctors may add liver function tests, since fatty liver disease can coexist with metabolic dysfunction.
In younger patients or in those with reproductive or endocrine symptoms, additional endocrine testing may be used. For example, if polycystic ovary syndrome is suspected, clinicians may evaluate androgen levels and related reproductive hormones. Thyroid function tests can be considered when symptoms suggest hypothyroidism, and other hormone studies may be ordered if there are signs of adrenal or pituitary disease. These tests do not diagnose acanthosis nigricans directly, but they help identify an associated condition that could explain it.
Imaging tests are not routinely needed for typical, stable cases. They become relevant when a doctor suspects an internal malignancy or another occult disease. In the rare paraneoplastic form, the skin changes may precede the diagnosis of cancer. If the presentation is concerning, clinicians may order imaging such as chest radiography, abdominal ultrasound, CT, or other studies guided by age, symptoms, and exam findings. Imaging helps search for tumors in the stomach, pancreas, lungs, or other organs depending on the suspected source. The aim is not to confirm the skin disorder itself, but to identify a hidden cause that may be driving it.
Functional tests can be useful when the key question is insulin resistance or diabetes risk. Examples include oral glucose tolerance testing, which measures how the body handles a standardized glucose load over time, and sometimes insulin response assessments in specialized settings. These studies can reveal impaired glucose handling even when fasting glucose is not yet clearly abnormal. In practice, they are most helpful when symptoms or risk factors are present but routine glucose testing is inconclusive.
Tissue examination through skin biopsy may be done if the diagnosis is uncertain or if the lesion has atypical features. A biopsy is not always necessary because acanthosis nigricans is often a clinical diagnosis. When performed, microscopic examination typically shows papillomatosis, hyperkeratosis, and mild acanthosis, which correspond to thickening of the epidermis and surface undulation. The findings help distinguish the lesion from other dermatoses and from pigmentary disorders that do not produce the same architecture. Biopsy can also exclude other skin diseases, including epidermal nevus, confluent and reticulated papillomatosis, psoriasis, or rarely a cutaneous malignancy.
Interpreting Diagnostic Results
Doctors interpret the results in the context of the skin findings, age, and overall health. A patient with classic velvety plaques in the neck or axillae, plus elevated blood glucose or insulin resistance markers, is often diagnosed with acanthosis nigricans associated with metabolic dysfunction. In that setting, the skin finding is a visible marker of an underlying metabolic state rather than a standalone disease.
If laboratory studies are normal but the lesions are typical and stable, the clinician may still diagnose acanthosis nigricans clinically and continue to observe for evolving metabolic issues. The absence of abnormal blood tests does not completely exclude the condition, particularly early in its course. In such cases, the medical reasoning shifts toward monitoring and reassessment rather than immediate exclusion.
When imaging or broader testing reveals a tumor or endocrine disorder, the skin diagnosis remains acanthosis nigricans, but the subtype is reclassified based on cause. This distinction matters because treatment focuses on the underlying condition. Improvement of the associated disorder often leads to partial or complete regression of the skin changes.
Pathology results from biopsy are also interpreted cautiously. Histology that shows papillomatosis and hyperkeratosis supports acanthosis nigricans, but the biopsy findings overlap with other papillary or hyperkeratotic skin conditions. For that reason, pathology confirms the skin architecture, while clinical context determines the final diagnosis.
Conditions That May Need to Be Distinguished
Several conditions can resemble acanthosis nigricans at first glance. Simple frictional hyperpigmentation, especially in people with obesity or skin-to-skin rubbing, can darken folds without the velvety thickening typical of acanthosis nigricans. Post-inflammatory hyperpigmentation may follow eczema, rash, or irritation and usually reflects discoloration rather than epidermal thickening.
Confluent and reticulated papillomatosis may produce brown papules and plaques on the trunk and can resemble the disease, but it tends to involve the central chest and back more than classic fold areas. Dermatosis neglecta and terra firma-forme dermatosis can also create dirty-looking or pigmented patches, though these often improve with cleansing or alcohol wiping. Tinea versicolor can alter skin color but usually has a fine scale and is caused by fungal overgrowth rather than epidermal thickening.
Rarely, lesions that appear similar may reflect epidermal nevus, lichen simplex chronicus, psoriasis in flexural areas, or other pigmentary disorders. The clinician distinguishes these by examining texture, distribution, scale, associated symptoms, and response to scraping, cleansing, or treatment. In adults with sudden, widespread, or mucosal involvement, doctors also consider paraneoplastic syndromes because malignant acanthosis nigricans can resemble the benign form but has different implications.
Factors That Influence Diagnosis
Several factors shape how aggressively clinicians investigate acanthosis nigricans. Age is important: in children and adolescents, obesity and insulin resistance are common explanations, whereas in older adults, especially with abrupt onset, the threshold for searching for systemic disease is lower. Severity and distribution also matter. Localized neck involvement in a patient with obesity may prompt metabolic testing, while extensive involvement, mucosal lesions, or rapid spread can justify broader evaluation.
Associated medical conditions influence the workup as well. A patient with diabetes, polycystic ovary syndrome, or metabolic syndrome may need less extensive investigation because the likely mechanism is clearer. Conversely, someone who is lean, not insulin resistant, and has no obvious endocrine explanation may require a more detailed search for medications, hormonal abnormalities, or, rarely, malignancy.
Ethnic background and skin tone can affect visibility of lesions but do not change the underlying diagnostic criteria. In darker skin tones, the hyperpigmentation may be more striking, yet the diagnosis still depends on the characteristic texture and location. A careful history and examination remain central because acanthosis nigricans is fundamentally a pattern recognition diagnosis supported by targeted testing.
Conclusion
Acanthosis nigricans is diagnosed through a combination of clinical recognition and selective testing. The visible signs are usually the starting point: velvety, thickened, darkened skin in body folds, often with a pattern that suggests insulin resistance or another systemic trigger. From there, clinicians use medical history and physical examination to identify likely causes and decide whether laboratory studies, endocrine evaluation, imaging, functional glucose testing, or skin biopsy are needed.
The diagnostic process is designed not only to confirm the skin finding, but also to explain why it has developed. That distinction is essential because acanthosis nigricans may be a marker of metabolic disease, a medication effect, an endocrine disorder, or, rarely, an internal malignancy. Accurate diagnosis therefore depends on combining skin assessment with a broader medical evaluation.